During the past decade, Schepens Eye Research Institute conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 1 clinical trials were completed, i.e. on average, 16.7% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 1 clinical trials were completed. i.e. 20% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Schepens Eye Research Institute" #1 collaborator was "National Eye Institute (NEI)" with 5 trials as a collaborator and "Chadwick Optical Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Schepens Eye Research Institute" are "Homonymous Hemianopia" (3 trials), "Hemianopsia" (2 trials), "Tunnel Vision" (2 trials), "Visual Field Constriction Bilateral" (2 trials) and "Visual Field Defect Homonymous Bilateral" (2 trials). Many other conditions were trialed in "Schepens Eye Research Institute" in a lesser frequency.

Most popular intervention types in "Schepens Eye Research Institute" are "Device" (5 trials), "Other" (2 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Collision warning device" (1 trials), "Field expansion view" (1 trials), "Fresnel Peripheral Prism (FPP) glasses" (1 trials), "High power (57 prism diopter) peripheral prism glasses" (1 trials) and "High power prisms" (1 trials). Other intervention names were less common.

The vast majority of trials in "Schepens Eye Research Institute" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Schepens Eye Research Institute". undefined are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Schepens Eye Research Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Schepens Eye Research Institute, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 7 trials that are defined as “Not Applicable".